Imunon, Inc. [IMNN] - Convertible Preferred Issuance
Imunon, Inc. is set to issue convertible preferred shares, although specific terms regarding pricing or amounts are not disclosed in the filing excerpt.
Why this matters
Imunon, Inc., a pharmaceutical company based in New Jersey and incorporated in Delaware, operates in the field of pharmaceutical preparations. The company has announced its intention to issue convertible preferred shares, as indicated in a recent SEC filing. However, the filing does not disclose specific terms such as pricing or the amount of the issuance. This move involves entering into a securities purchase agreement with Streeterville Capital, suggesting a strategic financial maneuver, although the precise motivations behind this issuance are not detailed in the available documents.